National New Veterinary Drugs

As the designated Guangdong Provincial Agricultural Technology Innovation Center, the New Veterinary Drug Engineering Technology Research Center, and the South China Agricultural University – Eastern Along Postdoctoral Innovation Practice Base, we are committed to advancing veterinary medicine through cutting-edge research.

To date, we have successfully developed and launched over 20 new licensed veterinary drugs and more than 10 first-to-market generic products. Flagship brands—including EarGel®, SkinCare®, XiBay®, OffLoad®, KetoFen®, Tyloxin®, and Footyl®—have all secured top-three market positions in their respective categories in China.

Innovation-Driven Development

Guided by an innovation-driven strategy, Along Pharma has been granted over 70 invention patents and recognized as one of China’s Top 10 R&D-Oriented Veterinary Drug Brands. As a benchmark enterprise in the development of chemical veterinary formulations, we have led numerous national and provincial scientific research initiatives.

We have pioneered seven innovative products for the prevention and treatment of obstetric diseases in dairy cows—each meeting internationally advanced or domestically leading standards.

Several of our proprietary process technologies have also reached international excellence, including:

Micronization technology for Rifaximin,
Advanced preparation process for Ketoprofen injection, and
Film-forming anti-freeze technology for Povidone-Iodine Teat Dip.
Our technological achievements have received prestigious recognitions:

The Oxytetracycline Uterine Infusion (“An Oxytetracycline Uterine Infusion and Its Preparation Method,” Patent No. ZL201010299047.4) was awarded an Outstanding Patent Award by Guangdong Province.

The Povidone-Iodine Teat Dip Solution (“A Dairy Cow Teat Anti-Freeze Disinfectant and Its Preparation Method,” Patent No. ZL201310485006.8) received the 12th China Patent Award.

The Cefquinome Sulfate Intramammary Infusion (“A Composition and Its Application,” Patent No. ZL201510607822.0) was honored with the 22nd China Patent Award.

Most recently, Along Pharma was awarded the 2024 Major Scientific and Technological Innovation Achievement Award in the Dairy Industry by the China Dairy Association—a testament to our ongoing commitment to advancing animal health through science and innovation.